Trust Infrastructure for Real-World Ecosystems

Dr Pramod Varma shared India’s experience building population-scale digital public infrastructure and explored what open, interoperable foundations can mean for economies facing rapid technological change.
Enabling Better Customer Experiences: Digital Identity in Action

How can digital identity make customer experiences simpler, safer and more useful — without leaving people behind?
Digital identity requires governance that puts people first

Christopher Bramwell, Chief Privacy Officer for the State of Utah, offered a global perspective on why digital identity requires governance that puts people first.
Designed for Real Life: How Everyday Moments Build the Digital ID Ecosystem

For digital identity to become part of everyday life, it needs to work in the moments that matter to people. Helen Littlewood of Cuscal Paymark described this as the “Friday night test”.
Sovereign AI, Indigenous Rights and the Architecture of Trust

The opening keynote at Digital Trust Hui Taumata 2026 explored how Aotearoa can embrace AI and digital trust while protecting individual agency, Māori rights and community governance.
Towards Universal Trust: Reflections from Digital Trust Hui Taumata 2026

On Tuesday 11 August, Digital Trust Hui Taumata 2026 brought together leaders from government, industry, technology, privacy, security and communities at Te Papa Tongarewa to explore a shared ambition: Towards Universal Trust.
The next challenge in employment? Building a more trustworthy ecosystem

Hiring has always been a process that depends on building trust.
When AI actus on our behalf, governance needs to follow

In Part 1, we looked at a simple question: when an AI assistant acts with someone’s identity and authority, who is accountable for what it does?
Who answers when a machine acts in your name?

At SSS – Cybersecurity Specialists, we spend a lot of time with the leaders who carry this risk. One question keeps coming up: when a machine acts in your organisation’s name, who answers for it?
The millionth-credential challenge

In pharmaceutical development, there’s a well-known principal called “the first-pill problem”. Brining a new medicine to market – discovery, preclinical research, clinical trials, regulatory approval, manufacturing, and the failures along the way – takes years and costs millions, sometimes billions.